Hot issues
The Partnership for Safe Medicines (PSM) today announced its strong support for the reintroduction of the Cooper Davis Devin Norring Act, a bipartisan effort aimed at curbing the online sale of deadly counterfeit and illicit drugs.
A policy change announced by U.S. Customs and Border Protection means that all FDA-regulated products are now subject to inspection at ports of entry.
503B outsourcing facilities make our drug supply more resilient, but 81% of 503Bs newly registered since June 2021 have never been inspected by FDA staff. Learn why we recommend changes to this important program.
Pill presses and molds are used to make fake pills with deadly consequences thousands of people every year. The number of Americans that take fake pills annually without a fatal event is even higher. Read our January through June 2025 report covering pill press seizures, policy developments, and legislation.
Avanish Kumar Jha and Rajnish Kumar Jha got 30-month sentences for selling counterfeit medicines—including vials of fake Keytruda—to U.S. buyers.
After a November 2024 inspection, the FDA issued a Form 483 to Empower Clinic Services highlighting violations related to compounded drug manufacturing practices at its East Windsor, New Jersey facility.
The change will affect the Google Ads and Google Shopping platforms starting in September 2025.
Our podcast covers the latest in pharma crime and medicine safety.
Like your information on video? Subscribe to our YouTube playlist!
Who's investigating a company selling research-grade weight loss injections? Find out..
Updates on two federal prosecutions.
Click the images below to see more recent videos.